ANXA1 and esophageal squamous cell carcinoma: This effect is mediated by suppressed ANXA1-FPR2 ligand-receptor interaction due to the gradual loss of ANXA1 expression in epithelial cells during ESCC development.8 These previous studies have provided paradigms for discovering the critical molecular events that promote the progression of precancerous lesions to cancerous lesions.